Results 121 to 130 of about 9,515 (211)

Bacteriophage Therapy Against <i>Shigella</i> spp.: A Precision Antimicrobial Strategy. [PDF]

Antibiotics (Basel)
Scarlata GGM, Belančić A, Štimac D, Fajkić A, Meštrović T, Abenavoli L.   +5 more
europepmc   +1 more source

A case of carbapenamase production in <i>Shigella flexneri</i> isolated in Ireland, 2025. [PDF]

Euro Surveill
Clarke C, Tuohy A, Duignan E, Mullane P, Carolan AM, Craig O, Miliotis G, Dillon C, Cormican M.   +8 more
europepmc   +1 more source

Rise of the Resistance: A Case of Resistant Shigellosis in an Immunocompetent Female Patient. [PDF]

Cureus
Saito A, Edwards J, Greeley AM.
europepmc   +1 more source

Shigella flexneri and Shigella sonnei among children under five in Kenya's urban informal settlement. [PDF]

Gut Pathog
Kioko C, Maingi JM, Mbae C, Otieno P, Kebenei C, Mbithi W, Njuguna A, Kamwethya S, Imoli D, Ideke D, Jepchirchir J, Kering K, Kariuki S.   +12 more
europepmc   +1 more source

Looking Beyond the Surface: A Case of Shigella Enterocolitis in a Patient Presenting With Weakness and Substance Use. [PDF]

Cureus
Lytle E, Le K, Le H.
europepmc   +1 more source

Anti-Shigella activity and killing kinetics of compounds from MMV Pathogen and COVID Boxes: Identifying leads against Shigellosis. [PDF]

Curr Res Pharmacol Drug Discov
Tchokouaha Yamthe LR, Kengne Mediesse F, Melogmo Dongmo YK, Matchuenkam Gayap SR, Dize D, Tsouh Fokou PV, Boyom FF.   +6 more
europepmc   +1 more source

Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023.

MMWR Morb Mortal Wkly Rep
Logan N, Birhane MG, McDonald SL, Alarcón J, Amador S, Anand M, Bachmann LH, Bernard K, Black LS, Chen AN, Cooley LA, Fortes ED, Gerard M, Jervis RH, Kimura AC, Lamba K, Latash J, Li L, Pederson G, Kauffman CP, Reynolds JL, Santiago R, Siemetzki-Kapoor U, Smole SC, Tagg KA, Vostok J, Webb HE, Francois Watkins LK, XDR Shigella Working Group.   +28 more
europepmc   +1 more source

<i>Shigella sonnei</i> and <i>Shigella flexneri</i>: Epidemiology supporting development of cross-protective vaccines. [PDF]

Hum Vaccin Immunother
Caradonna V, Hunyady A, Nakakana U, Iturriza M, Micoli F, Rossi O, Mancini F.   +6 more
europepmc   +1 more source

Isolation and characterization of lytic <i>Shigella</i> bacteriophages with rapid <i>in vitro</i> and <i>ex vivo</i> bactericidal activity. [PDF]

Front Cell Infect Microbiol
Shaheen N, Stricklin M, Kordesch M, Wang S.   +3 more
europepmc   +1 more source

Genomic and epidemiological characteristics of <i>Shigella boydii</i> in Australia, 1991-2022. [PDF]

Pathog Glob Health
Ibrahim AF, Ingle DJ, Webb JR, Howden BP, Andersson P, Polkinghorne BG, Wright R, Glass K, Kirk MD.   +8 more
europepmc   +1 more source